Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA

International Journal of Epidemiology

Volumn 26, Issue 1, 1997, Pages 58-63

  Lindberg, Gunnar ^a   Iso, Hiroyasu ^b   Råstam, Lennart ^c   Lundblad, Arne ^d   Folsom, Aaron R ^e  

^a Network for Pharmacoepidemiology Foundation   (Sweden)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c LUND UNIVERSITY   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Atherosclerosis; Caucasians; Coronary heart disease; Japanese; Sialic acid

Indexed keywords

FIBRINOGEN; SIALIC ACID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CAUCASIAN; DISEASE MARKER; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; RURAL AREA; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UNITED STATES; URBAN AREA;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MINNESOTA; N-ACETYLNEURAMINIC ACID; PROBABILITY; RISK FACTORS; RURAL POPULATION; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 0030994766     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/26.1.58     Document Type: Article

References (26)

1. Lindberg G, Eklund G A, Gullberg B, Råstam L. Serum sialic acid concentration and cardiovascular mortality. Br Med J 1991; 302: 143-46.
2. Lindberg G, Råstam L, Gullberg B, Eklund G A. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54 385 men and women during 20.5 years follow-up. Int J Epidemiol 1992; 21: 253-57.
3. Råstam L, Lindberg G, Folsom A R, Burke G L, Nilsson-Ehle P, Lundblad A. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. Int J Epidemiol 1996; 25: 955-60.
4. Watts G F, Crook M A, Haq S and Mandalia S. Serum sialic acid as an indicator of change in coronary artery disease. Metabolism 1995; 44: 147-48.
5. Keys A. Summary: Coronary heart disease in seven countries. Circulation 1970; 42 (Suppl. I): 186-98.
6. Pisa Z, Uemura K. Trends of mortality from ischaemic heart disease and other cardiovascular diseases in 27 countries, 1968-1977. World Health Stat Q 1982; 35: 11-47.
7. Iso H, Folsom A R, Sato S et al. Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscler Thromb 1993; 13: 783-90.
8. Iso H, Folsom A R, Koike K A, Sato S, Wu K K, Shimamoto T, Iida M, Komachi Y. Antigens of tissue plasminogen activator and plasminogen activator inhibitor 1: Correlates in nonsmoking Japanese and Caucasian men and women. Thromb Haemost 1993; 70: 475-80.
9. Atherosclerosis Risk in Communities Study Manual 9: Hemostasis determinations. The National Heart Lung and Blood Institute of the National Institute of Health. Collaborative Studies Coordinating Center. University of North Carolina, Chapel Hill, NC, 1987.
10. Gaubatz J, Curshing G. Quantitation, isolation, and characterization of human lipoprotein(a). Methods Enzymol 1986; 129: 167-86.
11. Jourdian G W, Dean L, Roscman S. The sialic acids XI. A periodate-resorsinol method for the quantitative estimation of free sialic acids and their glycosides. J Biol Chem 1971; 246: 430-35.
12. Gillum R F, Folsom A, Luepker R V et al. Sudden death and acute myocardial infarction in a metropolitan area, 1970-1980. The Minnesota Heart Survey. N Engl J Med 1983; 309: 1353-58.
13. Iso H, Folsom A R, Wu K K et al. Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors. Am J Epidemiol 1989; 130: 925-34.
14. Wakabayashi I, Sakamoto K, Yoshimoto S, Masui H. Relation of serum sialic acid to lipid concentrations, Br Med J 1992; 305: 562-63.
15. Kario K, Matsuo T. Relation between sialic acid concentrations and the haemostatic system in the elderly. Br Med J 1993; 306: 1650-51.
16. Taniuchi K, Chifu K, Hayashi N et al. A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants. Kobe J Med 1981; 27: 91-102.
17. von Henn K H, Gressner A M. The clinical significance of sialic acid in serum in benign and malignant diseases. J Clin Chem Clin Biochem 1987; 25: 423-30.
18. Crook M, Haq S, Haq M, Tutt P. The relationship of serum total siaiic acid with serum acute phase proteins and lipoprotein (a) in patients with severe hypertriglyceridaemia. Eur J Clin Invest 1994; 24: 179-81.
19. Crook M A, Tutt P, Pickup J C. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retionpathy. Diabetes Care 1993; 16: 57-60.
20. Crook M. The determination of plasma or serum sialic acid. Clin Biochem 1993; 26: 31-38.
21. Crook M, Tutt P. Serum sialic acid concentration in patients with hypertriglyceridaemia showing the Frederickson's IIB phenotype. Clinical Science 1992; 83: 593-95.
22. Haq M, Tutt P, Crook M. Plasma sialic acid in myocardial infarction. Biochem Soc Trans 1992; 20: 343s.
23. Lindberg G, Råstam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson B S. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers. Atherosclerosis 1993; 103: 123-29.
24. Stuart J, George A J, Davies A J, Aukland A, Hurlow R A. Haematological stress syndrome in atherosclerosis. J Clin Pathol 1981; 34: 464-67.
25. Meade T W, North W R S, Chakrabarti R et al. A Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980; 8177: 1050-54.
26. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-05.